Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value

Magdy Selim1, John N Fink, Sandeep Kumar

  • 1Department of Neurology, Division of Cerebrovascular Diseases, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass 02215, USA. mselim@caregroup.harvard.edu

Stroke
|August 3, 2002
PubMed
Abstract

Related Concept Videos